Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tofacitinib, an oral Janus kinase inhibitor, in patients from Mexico with rheumatoid arthritis: Pooled efficacy and safety analyses from Phase 3 and LTE studies.
Burgos-Vargas R, Cardiel M, Xibillé D, Pacheco-Tena C, Pascual-Ramos V, Abud-Mendoza C, Mahgoub E, Rahman M, Fan H, Rojo R, García E, Santana K. Burgos-Vargas R, et al. Among authors: mahgoub e. Reumatol Clin (Engl Ed). 2019 Jan-Feb;15(1):43-53. doi: 10.1016/j.reuma.2017.04.006. Epub 2017 May 25. Reumatol Clin (Engl Ed). 2019. PMID: 28552437 Free article. English, Spanish.
Assessment of clinical efficacy and safety in a randomized double-blind study of etanercept and sulfasalazine in patients with ankylosing spondylitis from Eastern/Central Europe, Latin America, and Asia.
Damjanov N, Shehhi WA, Huang F, Kotak S, Burgos-Vargas R, Shirazy K, Bananis E, Szumski A, Llamado LJ, Mahgoub E. Damjanov N, et al. Among authors: mahgoub e. Rheumatol Int. 2016 May;36(5):643-51. doi: 10.1007/s00296-016-3452-0. Epub 2016 Mar 11. Rheumatol Int. 2016. PMID: 26968844 Clinical Trial.
Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access.
Pavelka K, Akkoç N, Al-Maini M, Zerbini CAF, Karateev DE, Nasonov EL, Rahman MU, Pedersen R, Dinh A, Shen Q, Vasilescu R, Kotak S, Mahgoub E, Vlahos B. Pavelka K, et al. Among authors: mahgoub e. Rheumatol Int. 2017 Sep;37(9):1469-1479. doi: 10.1007/s00296-017-3749-7. Epub 2017 Jun 9. Rheumatol Int. 2017. PMID: 28597306 Clinical Trial.
The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study.
Moots RJ, Xavier RM, Mok CC, Rahman MU, Tsai WC, Al-Maini MH, Pavelka K, Mahgoub E, Kotak S, Korth-Bradley J, Pedersen R, Mele L, Shen Q, Vlahos B. Moots RJ, et al. Among authors: mahgoub e. PLoS One. 2017 Apr 27;12(4):e0175207. doi: 10.1371/journal.pone.0175207. eCollection 2017. PLoS One. 2017. PMID: 28448562 Free PMC article.
Erratum to: The prevalence and clinical characteristics of nonradiographic axial spondyloarthritis among patients with inflammatory back pain in rheumatology practices: a multinational, multicenter study.
Burgos-Vargas R, Wei JC, Rahman MU, Akkoc N, Haq SA, Hammoudeh M, Mahgoub E, Singh E, Llamado LJ, Shirazy K, Kotak S, Hammond C, Pedersen R, Shen Q, Vlahos B. Burgos-Vargas R, et al. Among authors: mahgoub e. Arthritis Res Ther. 2016 Jul 4;18(1):154. doi: 10.1186/s13075-016-1066-2. Arthritis Res Ther. 2016. PMID: 27377551 Free PMC article. No abstract available.
The prevalence and clinical characteristics of nonradiographic axial spondyloarthritis among patients with inflammatory back pain in rheumatology practices: a multinational, multicenter study.
Burgos-Varga R, Wei JC, Rahman MU, Akkoc N, Haq SA, Hammoudeh M, Mahgoub E, Singh E, Llamado LJ, Shirazy K, Kotak S, Hammond C, Pedersen R, Shen Q, Vlahos B. Burgos-Varga R, et al. Among authors: mahgoub e. Arthritis Res Ther. 2016 Jun 7;18(1):132. doi: 10.1186/s13075-016-1027-9. Arthritis Res Ther. 2016. PMID: 27267875 Free PMC article.
Correction: The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study.
Moots RJ, Xavier RM, Mok CC, Rahman MU, Tsai WC, Al-Maini MH, Pavelka K, Mahgoub E, Kotak S, Korth-Bradley J, Pedersen R, Mele L, Shen Q, Vlahos B. Moots RJ, et al. Among authors: mahgoub e. PLoS One. 2017 Jun 5;12(6):e0179308. doi: 10.1371/journal.pone.0179308. eCollection 2017. PLoS One. 2017. PMID: 28582423 Free PMC article.
114 results